NPY in Brain Fluid Linked to Heart Disease Risk — But the Effect Flips Based on Body Weight | Research

The takeaway

Cerebrospinal fluid NPY levels were associated with cardiovascular risk markers (ApoA-I), but the relationship reversed based on BMI — protective in normal weight individuals but a risk factor in overweight/obese people.

Role reversal by BMI
Brain NPY is cardiovascular-protective in normal weight but becomes a risk factor in overweight/obese individuals

What the researchers found

BMI moderates the CSF NPY–peripheral ApoA-I relationship (R²=0.144, β=-0.54, p<0.001). NPY was protective in normal weight (positive ApoA-I association) but a risk factor in overweight/obese (negative ApoA-I association).

Why it matters

This reveals that brain neuropeptides do not have fixed effects — their impact on cardiovascular risk depends on metabolic state. This could explain why obesity rewires the brain-heart connection and suggests that weight management may be needed to maintain NPY's protective cardiovascular role.

The numbers in context

Study examined the NPY-apolipoprotein association across BMI categories, finding significant moderation effects.

How the study worked

Cross-sectional study of 190 participants (73 normal weight, 117 overweight/obese). Measured NPY, ghrelin, orexin A, and oxytocin in CSF via lumbar puncture. Blood ApoA-I and ApoB measured peripherally. Moderation analysis by BMI.

Who was studied

Patients with CSF and blood sampling across BMI categories

What this study cannot tell us

Cross-sectional design cannot establish causation. CSF sampling is invasive, potentially limiting participant selection. The 190-person sample is moderate. ApoA-I and ApoB are surrogate cardiovascular markers, not clinical outcomes.

How to read the evidence

Moderate evidence: human study with CSF sampling and rigorous moderation analysis, but cross-sectional design and surrogate endpoints limit causal conclusions.

When this study was published

Published in 2024. Novel finding on how metabolic state modulates neuropeptide-cardiovascular connections.

The bigger picture

NPY is the most abundant neuropeptide in the brain and a key appetite regulator. This study reveals that the same peptide can be protective or harmful for the heart depending on body composition — a finding with implications for understanding why obesity is such a strong cardiovascular risk factor and how brain peptide signaling changes with weight.

Questions still open

What mechanism causes NPY's cardiovascular role to reverse in obesity?
Could weight loss restore NPY's protective association with ApoA-I?
Do GLP-1 weight-loss drugs affect CSF NPY levels and restore its protective cardiovascular role?

Common questions

How does NPY affect heart disease risk?

NPY's cardiovascular effect depends on body weight. In normal-weight people, higher brain NPY is associated with protective ApoA-I levels. In overweight/obese people, this relationship reverses — higher NPY is associated with lower ApoA-I, a cardiovascular risk factor.

Does losing weight change how NPY affects the heart?

This study did not test weight loss interventions, but the findings suggest that maintaining a healthy weight may be important for preserving NPY's protective cardiovascular role. Future studies should examine whether weight loss reverses the harmful NPY-ApoA-I pattern.

Read the original research

Association of cerebrospinal fluid NPY with peripheral ApoA: a moderation effect of BMI.

Nutrition & metabolism, 21(1), 52

View on PubMed ↗Publisher’s paper ↗

Citation

Zhao, Danyang; Han, Xiaoli; Mu, Qingshuang; Wu, Yan; Shan, Ligang; Su, Lidong; Wang, Wenyan; Wang, Pengxiang; Kang, Yimin; Wang, Fan. (2024). Association of cerebrospinal fluid NPY with peripheral ApoA: a moderation effect of BMI.. Nutrition & metabolism, 21(1), 52. https://doi.org/10.1186/s12986-024-00828-6